CRMD vs. PLTR
CRMD (CorMedix Inc.) and PLTR (Palantir Technologies Inc.) are both stocks. CRMD operates in Biotechnology (Healthcare), while PLTR operates in Software - Infrastructure (Technology). Over the past 5 years, CRMD returned 2.01%/yr vs 42.70%/yr for PLTR. At a 0.28 correlation, their price movements are largely independent.
Performance
CRMD vs. PLTR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRMD achieves a -29.23% return, which is significantly lower than PLTR's -20.00% return.
CRMD
- 1D
- 0.73%
- 1M
- 4.18%
- YTD
- -29.23%
- 6M
- -20.25%
- 1Y
- -34.73%
- 3Y*
- 16.99%
- 5Y*
- 2.01%
- 10Y*
- -4.90%
PLTR
- 1D
- -6.55%
- 1M
- -2.62%
- YTD
- -20.00%
- 6M
- -19.24%
- 1Y
- 6.78%
- 3Y*
- 113.95%
- 5Y*
- 42.70%
- 10Y*
- —
CRMD vs. PLTR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
CRMD CorMedix Inc. | -29.23% | 43.58% | 115.43% | -10.90% | -7.25% | -38.76% | 23.22% |
PLTR Palantir Technologies Inc. | -20.00% | 135.03% | 340.48% | 167.45% | -64.74% | -22.68% | 147.89% |
Correlation
The correlation between CRMD and PLTR is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.16 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.21 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.28 |
Correlation (All Time) Calculated using the full available price history since Oct 1, 2020 | 0.28 |
The correlation between CRMD and PLTR shifts across timeframes, from 0.16 (1 year) to 0.28 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
CRMD:
$765.27M
PLTR:
$365.59B
CRMD:
$2.10
PLTR:
$0.89
CRMD:
3.92
PLTR:
160.02
CRMD:
1.77
PLTR:
69.88
CRMD:
1.75
PLTR:
43.27
CRMD:
$400.05M
PLTR:
$5.22B
CRMD:
$343.39M
PLTR:
$4.39B
CRMD:
$207.97M
PLTR:
$2.01B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRMD vs. PLTR — Risk / Return Rank
CRMD
PLTR
CRMD vs. PLTR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for CorMedix Inc. (CRMD) and Palantir Technologies Inc. (PLTR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CRMD | PLTR | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.51 | 0.13 | -0.64 |
Sortino ratioReturn per unit of downside risk | -0.34 | 0.53 | -0.87 |
Omega ratioGain probability vs. loss probability | 0.95 | 1.07 | -0.12 |
Calmar ratioReturn relative to maximum drawdown | -0.56 | 0.18 | -0.74 |
Martin ratioReturn relative to average drawdown | -0.83 | 0.33 | -1.17 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| CRMD | PLTR | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.51 | 0.13 | -0.64 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.03 | 0.66 | -0.63 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.05 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.04 | 0.88 | -0.92 |
Drawdowns
CRMD vs. PLTR - Drawdown Comparison
The maximum CRMD drawdown since its inception was -98.28%, which is greater than PLTR's maximum drawdown of -84.62%. Use the drawdown chart below to compare losses from any high point for CRMD and PLTR.
Loading charts...
Drawdown Indicators
| CRMD | PLTR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.28% | -84.62% | -13.66% |
Max Drawdown (1Y)Largest decline over 1 year | -62.26% | -38.19% | -24.07% |
Max Drawdown (3Y)Largest decline over 3 years | -62.26% | -40.61% | -21.65% |
Max Drawdown (5Y)Largest decline over 5 years | -66.91% | -79.14% | +12.23% |
Max Drawdown (10Y)Largest decline over 10 years | -94.77% | — | — |
Current DrawdownCurrent decline from peak | -83.32% | -31.36% | -51.96% |
Average DrawdownAverage peak-to-trough decline | -76.98% | -40.31% | -36.67% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 41.81% | 20.40% | +21.41% |
Volatility
CRMD vs. PLTR - Volatility Comparison
The current volatility for CorMedix Inc. (CRMD) is 12.63%, while Palantir Technologies Inc. (PLTR) has a volatility of 18.39%. This indicates that CRMD experiences smaller price fluctuations and is considered to be less risky than PLTR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CRMD | PLTR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.63% | 18.39% | -5.76% |
Volatility (6M)Calculated over the trailing 6-month period | 52.14% | 38.32% | +13.82% |
Volatility (1Y)Calculated over the trailing 1-year period | 68.84% | 51.70% | +17.14% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 77.14% | 65.41% | +11.73% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 91.78% | 69.86% | +21.92% |
Dividends
CRMD vs. PLTR - Dividend Comparison
Neither CRMD nor PLTR has paid dividends to shareholders.
Financials
CRMD vs. PLTR - Financials Comparison
This section allows you to compare key financial metrics between CorMedix Inc. and Palantir Technologies Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CRMD vs. PLTR - Profitability Comparison
CRMD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, CorMedix Inc. reported a gross profit of 105.12M and revenue of 127.43M. Therefore, the gross margin over that period was 82.5%.
PLTR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Palantir Technologies Inc. reported a gross profit of 1.42B and revenue of 1.63B. Therefore, the gross margin over that period was 86.8%.
CRMD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, CorMedix Inc. reported an operating income of 63.66M and revenue of 127.43M, resulting in an operating margin of 50.0%.
PLTR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Palantir Technologies Inc. reported an operating income of 754.00M and revenue of 1.63B, resulting in an operating margin of 46.2%.
CRMD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, CorMedix Inc. reported a net income of 38.60M and revenue of 127.43M, resulting in a net margin of 30.3%.
PLTR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Palantir Technologies Inc. reported a net income of 870.53M and revenue of 1.63B, resulting in a net margin of 53.3%.
Frequently Asked Questions
CRMD and PLTR have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PLTR has higher volatility (18.39%) compared to CRMD (12.63%). In terms of maximum drawdown, CRMD dropped -98.28% vs PLTR's -84.62%.
PLTR currently has the higher Sharpe Ratio (0.13 vs -0.51), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CRMD and PLTR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer